Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta‐analysis of risk factors

…, FA De Falco, G De Maria, M Elia, S Franceschetti… - …, 2016 - Wiley Online Library
Objective Seizures may occur in close temporal association with a stroke or after a variable
interval. Moreover, epilepsy is often encountered in patients with leukoaraiosis. Although …

Cellular biology of epileptogenesis

G Avanzini, S Franceschetti - The Lancet Neurology, 2003 - thelancet.com
The ionic currents that underlie the mechanisms of epileptogenesis have been systematically
characterised in different experimental preparations. The recent elucidation of the …

Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures

…, M Mehndiratta, K Venkateshwaralu, S Franceschetti… - Neurology, 2012 - AAN Enterprises
Objective: To evaluate the efficacy and safety of perampanel 2, 4, and 8 mg/day added to 1–3
concomitant antiepileptic drugs (AEDs) in patients with uncontrolled partial-onset seizures. …

Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine

…, R Rusconi, P Tarantino, L Mumoli, S Franceschetti… - …, 2013 - Wiley Online Library
Purpose To report the identification of the T1174S SCN1A (Na V 1.1) mutation in a three‐generation
family with both epileptic and familial hemiplegic migraine ( FHM ) phenotypes and …

[PDF][PDF] Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage

…, J Damiano, S Franceschetti, S Carpenter… - The American Journal of …, 2012 - cell.com
We performed hypothesis-free linkage analysis and exome sequencing in a family with two
siblings who had neuronal ceroid lipofuscinosis (NCL). Two linkage peaks with maximum …

The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development

…, M Lucioni, F Tabbò, R Serra, S Franceschetti… - Journal of Experimental …, 2012 - rupress.org
… In brief, HMW genomic DNA was restriction enzyme digested, ligated, PCR amplified,
purified, labeled, fragmented, and hybridized to the arrays according to the manufacturer’s

A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy

…, S Franceschetti, R Michelucci, S Markkinen… - Nature …, 2015 - nature.com
Progressive myoclonus epilepsies (PMEs) are a group of rare, inherited disorders manifesting
with action myoclonus, tonic-clonic seizures and ataxia. We sequenced the exomes of 84 …

Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome

…, S Rasi, V Spina, S Franceschetti… - British journal of …, 2008 - Wiley Online Library
Predictors of chronic lymphocytic leukaemia (CLL) transformation to Richter syndrome (RS)
are not established and were investigated in 185 consecutive CLL cases. Actuarial …

Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP

…, B Botto, S Ferrero, S Franceschetti… - Blood, The Journal …, 2012 - ashpublications.org
Role of interim-PET (I-PET) in diffuse large B-cell Lymphoma (DLBCL) is controversial. To
determine predictive value of I-PET on progression-free survival (PFS), we enrolled 88 first-…

[PDF][PDF] Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals

…, H El-Naggar, L Canafoglia, S Franceschetti… - The American Journal of …, 2019 - cell.com
Sequencing-based studies have identified novel risk genes associated with severe epilepsies
and revealed an excess of rare deleterious variation in less-severe forms of epilepsy. To …